Sivagurunathan Narmadhaa, Gnanasekaran Priyadharshini, Calivarathan Latchoumycandane
Molecular Pharmacology and Toxicology Laboratory, Department of Biotechnology, School of Life Sciences, Central University of Tamil Nadu, Thiruvarur, India.
Degener Neurol Neuromuscul Dis. 2023 Jan 26;13:1-13. doi: 10.2147/DNND.S361526. eCollection 2023.
Parkinson's disease (PD) is one of the most common progressive neurodegenerative diseases caused by the loss of dopamine-producing neuronal cells in the region of substantia nigra pars compacta of the brain. During biological aging, neuronal cells slowly undergo degeneration, but the rate of cell death increases tremendously under some pathological conditions, leading to irreversible neurodegenerative diseases. By the time symptoms of PD usually appear, more than 50 to 60% of neuronal cells have already been destroyed. PD symptoms often start with tremors, followed by slow movement, stiffness, and postural imbalance. The etiology of PD is still unknown; however, besides genetics, several factors contribute to neurodegenerative disease, including exposure to pesticides, environmental chemicals, solvents, and heavy metals. Postmortem brain tissues of patients with PD show mitochondrial abnormalities, including dysfunction of the electron transport chain. Most chemicals present in our environment have been shown to target the mitochondria; remarkably, patients with PD show a mild deficiency in NADH dehydrogenase activity, signifying a possible link between PD and mitochondrial dysfunction. Inhibition of electron transport complexes generates free radicals that further attack the macromolecules leading to neuropathological conditions. Apart from that, oxidative stress also causes neuroinflammation-mediated neurodegeneration due to the activation of microglial cells. However, the mechanism that causes mitochondrial dysfunction, especially the electron transport chain, in the pathogenesis of PD remains unclear. This review discusses the recent updates and explains the possible mechanisms of mitochondrial toxicant-induced neuroinflammation and neurodegeneration in PD.
帕金森病(PD)是最常见的进行性神经退行性疾病之一,由大脑黑质致密部中产生多巴胺的神经元细胞丢失所致。在生物衰老过程中,神经元细胞会缓慢发生退化,但在某些病理条件下细胞死亡速度会大幅增加,从而导致不可逆的神经退行性疾病。通常在帕金森病症状出现时,超过50%至60%的神经元细胞已经被破坏。帕金森病症状通常始于震颤,随后是运动迟缓、僵硬和姿势失衡。帕金森病的病因仍不明确;然而,除了遗传因素外,还有几个因素会导致神经退行性疾病,包括接触农药、环境化学物质、溶剂和重金属。帕金森病患者的死后脑组织显示出线粒体异常,包括电子传递链功能障碍。我们环境中存在的大多数化学物质已被证明会靶向线粒体;值得注意的是,帕金森病患者的NADH脱氢酶活性存在轻度缺陷,这表明帕金森病与线粒体功能障碍之间可能存在联系。电子传递复合物的抑制会产生自由基,进一步攻击大分子,导致神经病理状况。除此之外,氧化应激还会由于小胶质细胞的激活而导致神经炎症介导的神经退行性变。然而,在帕金森病发病机制中导致线粒体功能障碍,尤其是电子传递链功能障碍的机制仍不清楚。本综述讨论了最新进展,并解释了线粒体毒物诱导帕金森病神经炎症和神经退行性变的可能机制。